ABSTRACT

The Prevalence of mental disorders in Indonesia based on Riskesdas 2018 shows an increase compared to Riskesdas 2013, up form 1,7% to 7%. The increase in cases of mental disorders can cause the quantity of psychopharmaca therapy to increase so an evaluation is needed regarding its use. This study aims to determine the profile of psychopharmaca use in outpatients at RSJ Prof. Dr. Soerojo Hospital Magelang based on type and quantity in DDD units and DU% profile. The methods used in this study were Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) and Drug Utilization 90% (DU 90%). This research was carried out descriptively, by collecting data retrospectively which was summarized from the Hospital Information System (SIRS) at RSJ Prof. Dr. Soerojo Hospital Magelang in 2021. The results showed that the psychopharmaca used in 2021 were 14 types of drugs. The three most widely used psychopharmaca drugs were haloperidol at 7554,06 DDD/1000 KPRJ, trifluoperazine at 4984,15 DDD/1000 KPRJ, and alprazolam at 4178,54 DDD/1000 KPRJ. Psychopharmaca drugs included in the 90% DU segment are haloperidol, trifluoperazine, alprazolam, amitriptyline, diazepam, and clozapine. 

Keywords : Mental disorders, Psychopharmaca, ATC/DDD, DU90%, RSJ